Sign In
Buy GRTS
$0.0322
+0 (+0%)
At Close: Nov 05, 2024
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
11:38am, Wednesday, 01'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) * Athersys Inc (NASDAQ: ATHX) * Forty Seven Inc (NA
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 30.) * Athersys Inc (NASDAQ: ATHX) (reacted to $7-milli
7 Psychedelic Therapy Companies Addressing Mental Health
03:20pm, Thursday, 26'th Mar 2020
Remember that time where after sipping a little too much Electric Kool-Aid you ripped the bathroom sink out of the wall as you suffered through a self-inflicted bout of schizophrenia – only to emerg
Contrasting BIO-TECHNE (NASDAQ:TECH) & Gritstone Oncology (NASDAQ:GRTS)
07:04am, Thursday, 26'th Mar 2020
BIO-TECHNE (NASDAQ:TECH) and Gritstone Oncology (NASDAQ:GRTS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, i
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
BTIG's stocks for the storm
09:30pm, Sunday, 15'th Mar 2020
News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
Earnings Update: Gritstone Oncology, Inc. Just Reported And Analysts Are Boosting Their Estimates
12:30pm, Friday, 13'th Mar 2020
Shareholders in Gritstone Oncology, Inc. (NASDAQ:GRTS) had a terrible week, as shares crashed 28% to US$5.60 in the...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
01:01pm, Wednesday, 11'th Mar 2020
EMERYVILLE, Calif., March 11, 2020 -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies.
MindMed Lists On NEO Exchange, Becomes First Psychedelics Company To Go Public
12:00am, Wednesday, 04'th Mar 2020
The Canadian NEO Exchange announced Tuesday that neuro-pharmaceutical company Mind Medicine Inc. (OTC:MMEDF) (NEO: MMED) will make its public market debut under the symbol...
Gritstone Oncology to Present at Two Investor Conferences in March
09:00pm, Tuesday, 25'th Feb 2020
EMERYVILLE, Calif., Feb. 25, 2020 -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight.
Analysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness
05:09pm, Tuesday, 25'th Feb 2020
With the coronavirus outbreak spreading rapidly in countries beyond China, so is the fear among investors. Yesterday marked the S&P 500’s worst one-day performance since February 2018 as the index s
Head-To-Head Comparison: Gritstone Oncology (NASDAQ:GRTS) & Osiris Therapeutics (NASDAQ:OSIR)
06:46am, Saturday, 22'nd Feb 2020
Gritstone Oncology (NASDAQ:GRTS) and Osiris Therapeutics (OTCMKTS:OSIR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the stre
Move over, pot: Psychedelic drug companies gear up to list on Canadian stock exchanges
03:45pm, Tuesday, 11'th Feb 2020
Companies developing treatments from LSD, ketamine and the active ingredient in magic mushrooms are finding interest from investors, including Kevin O’Leary
